You are here: Welcome » Vaccine Hesitancy

Differences

This shows you the differences between two versions of the page.

Link to this comparison view

Both sides previous revisionPrevious revision
Next revision
Previous revision
Both sides next revision
vaccine_hesitancy [2022/01/17 11:21]
robert [Vaccine Hesitancy]
vaccine_hesitancy [2022/03/30 14:23] (current)
pamela [Office of Science and Technology Policy (OTSP)]
Line 10: Line 10:
  
 On September 14, 2020, the [[Globe and Mail]] published an opinion article titled "A vaccine may not be the simple solution we are hoping for" written by Dr. [[Zain Chagla]] (an Associate Professor at [[McMaster University]], Dr. [[Isaac Bogoch]] (associate professor at the [[University of Toronto]], and Dr. [[Sumon Chakrabarti]] (lecturer at the [[University of Toronto]].) The authors argued that the most likely scenario for COVID-19 was a vaccine that "prevents some but not all person-to-person SARS-CoV-2 transmission," and that "high rates of immunization are needed for maximum effectiveness". To accomplish this, the authors suggest "proactive messaging" to achieve "high vaccine uptake globally", and using a campaign to mass-vaccinate with the influenza vaccine as an opportunity "to troubleshoot for an effective COVID-19 vaccine rollout campaign".((Chagla, Z., Bogoch, I., & Chakrabarti, S. (2020, September 14). //Opinion: A vaccine may not be the simple solution we are hoping for.// The Globe and Mail. https://archive.ph/3BC6U))  On September 14, 2020, the [[Globe and Mail]] published an opinion article titled "A vaccine may not be the simple solution we are hoping for" written by Dr. [[Zain Chagla]] (an Associate Professor at [[McMaster University]], Dr. [[Isaac Bogoch]] (associate professor at the [[University of Toronto]], and Dr. [[Sumon Chakrabarti]] (lecturer at the [[University of Toronto]].) The authors argued that the most likely scenario for COVID-19 was a vaccine that "prevents some but not all person-to-person SARS-CoV-2 transmission," and that "high rates of immunization are needed for maximum effectiveness". To accomplish this, the authors suggest "proactive messaging" to achieve "high vaccine uptake globally", and using a campaign to mass-vaccinate with the influenza vaccine as an opportunity "to troubleshoot for an effective COVID-19 vaccine rollout campaign".((Chagla, Z., Bogoch, I., & Chakrabarti, S. (2020, September 14). //Opinion: A vaccine may not be the simple solution we are hoping for.// The Globe and Mail. https://archive.ph/3BC6U)) 
 +
 +=====  Office of Science and Technology Policy (OTSP)  =====
 +More than a dozen in the 140-person White House office are current or former employees of Schmidt
 +By Morgan Phillips, Politics Reporter For Dailymail 28 March 2022
 +
 +REVEALED - Google billionaire [[:Eric Schmidt]] has PAID the salaries of staff inside Biden's science office and has been quietly lobbying on policy since the Obama administration
 +
 +Schmidt, who stepped down in his role at [[:Google]]'s parent company Alphabet in 2020, now serves on the board of numerous tech companies. Schmidt even indirectly paid the salaries of OTSP employees Former OTSP general counsel Rachel Wallace repeatedly raised concerns over Schmidt's influence. She believes her concerns were the source of the wrath she faced from OTSP's former head [[:Eric Lander]], who stepped down recently for bullying. Lander and Schmidt are close associates.
 +
 +Schmidt even indirectly paid the salaries of OTSP employees, according to Politico. Schmidt's charity arm, Schmidt Futures, paid the salaries of two science office employees while they worked as unpaid consultants. For six weeks, the foundation paid the salary of current chief of staff, [[:Marc Aidinoff]], who is now one of the most senior officials in the shakeup after Lander's resignation. 
 +
 +Former OTSP official [[:Tom Kalil]], chief innovation officer at Schmidt Futures, also remained on the charity's payroll for four months while he was advising the OTSP as an unpaid consultant. He left the office after ethics complaints.
 +
 +Two other OTSP officials continued working part-time at the Broad Institute of [[:Harvard]] and [[:MIT]], a biotech facility formerly led by Lander where Schmidt serves on the board. Both have since left OTSP. Two others had their salaries paid by the [[:Federation of American Scientists]], that Schmidt pays into. ((https://web.archive.org/web/20220329051931/https://www.dailymail.co.uk/news/article-10661039/Google-billionaire-Eric-Schmidt-PAID-salaries-staff-inside-Bidens-science-office.html))
 +
 +   
 +
 +
  
Back to top